Pr WESTEEL Virginie

Fiche personne


coordonnées

Hôpital Jean Minjoz
3 boulevard Alexandre Fleming
25030 BESANCON Cedex

+33 3 81 66 88 04

virginie.westeel@univ-fcomte.fr

Territoire

Franche-Comté

Statut

Hospitalo-Universitaire

Recherche

Expertises :
- Clinique:Oncologie Médicale
- Clinique:Pneumologie
- Cancer:Poumon

Publications


High risk of lung cancer in surfactant-related gene variant carriers.

Brudon A, Legendre M, Mageau A, Bermudez J, Bonniaud P, Bouvry D, Cadranel J, Cazes A, Crestani B, Dégot T, Delestrain C, Diesler R, Epaud R, Philippot Q, Theou-Anton N, Kannengiesser C, Ba I, Debray MP, Fanen P, Manali E, Papiris S, Nathan N, Amselem S, Gondouin A, Guillaumot A, Andréjak C, Jouneau S, Beltramo G, Uzunhan Y, Galodé F, Westeel V, Mehdaoui A, Hirschi S, Leroy S, Marchand-Adam S, Nunes H, Picard C, Prevot G, Reynaud-Gaubert M, De Vuyst P, Wemeau L, Defossez G, Zalcman G, Cottin V, Borie R,

Eur Respir J. 2024 04 4;:

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.

Chu Q, Perrone F, Greillier L, Tu W, Piccirillo MC, Grosso F, Lo Russo G, Florescu M, Mencoboni M, Morabito A, Cecere FL, Ceresoli GL, Dawe DE, Zucali PA, Pagano M, Goffin JR, Sanchez ML, Gridelli C, Zalcman G, Quantin X, Westeel V, Gargiulo P, Delfanti S, Tu D, Lee CW, Leighl N, Sederias J, Brown-Walker P, Luo Y, Lantuejoul S, Tsao MS, Scherpereel A, Bradbury P, Laurie SA, Seymour L

Lancet. 2023 11 3;:

Safety and tolerability of weekly docetaxel plus nintedanib: A phase I trial after first-line chemotherapy failure in NSCLC.

Westeel V, Schuette W, Urban T, Radonjic D, von Wangenheim U, Lorence RM, Reck M

PLoS One. 2023 10 17;18(10):e0292307

Voir plus